INS and metabolic dysfunction-associated steatotic liver disease: This bidirectional relationship promotes weight gain and worsens metabolic outcomes such as insulin resistance, impaired glucose tolerance, elevated fasting insulin levels, dyslipidemia, and increased risk for type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).